HRP20000496A2 - Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers - Google Patents

Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers Download PDF

Info

Publication number
HRP20000496A2
HRP20000496A2 HR20000496A HRP20000496A HRP20000496A2 HR P20000496 A2 HRP20000496 A2 HR P20000496A2 HR 20000496 A HR20000496 A HR 20000496A HR P20000496 A HRP20000496 A HR P20000496A HR P20000496 A2 HRP20000496 A2 HR P20000496A2
Authority
HR
Croatia
Prior art keywords
formula
pyridone
hydroxy
use according
residue
Prior art date
Application number
HR20000496A
Other languages
English (en)
Croatian (hr)
Inventor
Manfred Bohn
Karl Theodor Kraemer
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of HRP20000496A2 publication Critical patent/HRP20000496A2/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
HR20000496A 1998-01-24 1999-01-11 Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers HRP20000496A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19802708A DE19802708A1 (de) 1998-01-24 1998-01-24 Verwendung von hydroxypyridon-haltigen Puderzubereitungen zur Behandlung von Unterschenkel- und Druckgeschwüren
PCT/EP1999/000105 WO1999037300A1 (fr) 1998-01-24 1999-01-11 Utilisation de preparations pulverulentes contenant de l'hydroxypyridone pour le traitement d'ulceres cruraux et d'ulceres de compression

Publications (1)

Publication Number Publication Date
HRP20000496A2 true HRP20000496A2 (en) 2000-12-31

Family

ID=7855595

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20000496A HRP20000496A2 (en) 1998-01-24 1999-01-11 Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers

Country Status (27)

Country Link
US (1) US6534528B1 (fr)
EP (1) EP1049468B1 (fr)
JP (1) JP5127091B2 (fr)
KR (1) KR100597332B1 (fr)
CN (1) CN1128619C (fr)
AR (1) AR016445A1 (fr)
AT (1) ATE360418T1 (fr)
AU (1) AU752406B2 (fr)
BR (1) BR9907734A (fr)
CA (1) CA2319359C (fr)
CY (1) CY1106684T1 (fr)
DE (2) DE19802708A1 (fr)
DK (1) DK1049468T3 (fr)
ES (1) ES2285829T3 (fr)
HR (1) HRP20000496A2 (fr)
HU (1) HU228824B1 (fr)
IL (1) IL137453A (fr)
ME (1) ME00390B (fr)
NZ (1) NZ505898A (fr)
PL (1) PL192550B1 (fr)
PT (1) PT1049468E (fr)
RS (1) RS50903B (fr)
RU (1) RU2212239C2 (fr)
SI (1) SI1049468T1 (fr)
SK (1) SK285350B6 (fr)
TR (1) TR200002118T2 (fr)
WO (1) WO1999037300A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001122804A (ja) * 1999-10-28 2001-05-08 Sato Pharmaceutical Co Ltd リン酸コーンスターチ配合外用医薬組成物
EP1354586A1 (fr) * 2002-04-20 2003-10-22 Aventis Pharma Deutschland GmbH Utilisation de dérivés de l'hydroxypyridone pour soigner des plaies
US20060257439A1 (en) * 2005-03-29 2006-11-16 Sabnis Ram W Cleansing compositions with color changing indicator
RU2326665C1 (ru) * 2007-04-03 2008-06-20 Марвел ЛайфСайнсез Лимитед, Великобритания Средство, обладающее противогипоксическим, противоинсультным, улучшающим память действием
BR112013001953A2 (pt) * 2010-07-27 2018-05-15 Clariant Finance Bvi Ltd uso de hidroxipiridonas ou sais dos mesmos para a estabilização de peróxido de hidrogênio ou substâncias doadoras de peróxido de hidrogênio
MX2013001095A (es) * 2010-07-27 2013-03-12 Clariant Finance Bvi Ltd Composiciones que comprenden peroxido de hidrogeno o sustancias donadoras de peroxido de hidrogeno.
WO2016164308A1 (fr) 2015-04-06 2016-10-13 Subdomain, Llc Polypeptides contenant un domaine de liaison de novo et leurs utilisations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2540218A (en) 1947-08-25 1951-02-06 Squibb & Sons Inc 2-hydroxy-pyridine-n-oxide and process for preparing same
DE3779352D1 (de) 1986-04-18 1992-07-02 Hoechst Ag 1-hydroxy-2-pyridone, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten, sowie bei der herstellung der 1-hydroxy-2-pyridone gebildete zwischenprodukte.
JPS63264504A (ja) * 1987-04-17 1988-11-01 Shinto Paint Co Ltd 工業用防カビ組成物
US4956184A (en) * 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
CA2046801C (fr) * 1990-08-07 2002-02-26 Peter D. Davis Pyrroles substitues
DE4333893A1 (de) * 1993-10-05 1995-04-06 Hoechst Ag Kosmetische Zubereitungen
ATE217524T1 (de) * 1995-12-04 2002-06-15 Aventis Pharma Gmbh Verwendung von 1-hydroxy-2-pyridonen zur behandlung von schwer therapierbaren schleimhauterkrankungen

Also Published As

Publication number Publication date
US6534528B1 (en) 2003-03-18
SK285350B6 (sk) 2006-11-03
EP1049468A1 (fr) 2000-11-08
TR200002118T2 (tr) 2000-12-21
JP2002501020A (ja) 2002-01-15
IL137453A (en) 2005-11-20
PL342055A1 (en) 2001-05-21
CA2319359C (fr) 2008-03-18
MEP55908A (en) 2011-05-10
PL192550B1 (pl) 2006-11-30
SK10892000A3 (sk) 2000-12-11
BR9907734A (pt) 2000-10-17
ATE360418T1 (de) 2007-05-15
YU43700A (sh) 2003-08-29
AR016445A1 (es) 2001-07-04
RU2212239C2 (ru) 2003-09-20
SI1049468T1 (sl) 2007-08-31
NZ505898A (en) 2002-06-28
DE59914312D1 (de) 2007-06-06
HU228824B1 (en) 2013-05-28
IL137453A0 (en) 2001-07-24
CA2319359A1 (fr) 1999-07-29
DE19802708A1 (de) 1999-07-29
EP1049468B1 (fr) 2007-04-25
CN1288380A (zh) 2001-03-21
HK1034447A1 (en) 2001-10-26
CY1106684T1 (el) 2012-05-23
AU752406B2 (en) 2002-09-19
RS50903B (sr) 2010-08-31
HUP0200851A3 (en) 2003-05-28
DK1049468T3 (da) 2007-07-30
KR20010034325A (ko) 2001-04-25
KR100597332B1 (ko) 2006-07-10
AU2278799A (en) 1999-08-09
JP5127091B2 (ja) 2013-01-23
ES2285829T3 (es) 2007-11-16
ME00390B (me) 2011-05-10
WO1999037300A1 (fr) 1999-07-29
PT1049468E (pt) 2007-05-31
HUP0200851A1 (hu) 2002-07-29
CN1128619C (zh) 2003-11-26

Similar Documents

Publication Publication Date Title
JP2010077143A (ja) 創傷治療用外用剤
TR200101903T2 (tr) Yeni malonik asit türevleri, bunların preparasyon işlemleri.
JP2018525348A (ja) 皮膚の炎症を抑制するイガイ接着タンパク質製品及びその適用
JPH08208488A (ja) 皮膚外用剤
GB2048070A (en) Medication for Open Wounds
JP6169693B2 (ja) 次亜塩素酸およびアミノ酸を含む創傷およびびらんを治療するための製剤
CA2319359C (fr) Utilisation de preparations pulverulentes contenant de l'hydroxypyridone pour le traitement d'ulceres cruraux et d'ulceres de compression
JP2014526487A (ja) 種々の原因の末梢性潰瘍の治療用組成物
EP2570124B1 (fr) Compositions d'oleuropéine pour la cicatrisation de plaies et d'ulcères chez des personnes âgées et/ou diabétiques
CZ295316B6 (cs) Léčivo k léčbě bércových vředů a proleženin
MXPA00007000A (en) Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers
HK1034447B (en) Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers
RU2122401C1 (ru) Ранозаживляющая композиция
RU2546030C1 (ru) Средство "ихтиосин"
JP2007277135A (ja) 創傷治療用外用剤
WO2007084127A1 (fr) Utilisation de gluten en tant qu'agent cicatrisant pour le traitement de plaies
Steenvoorde et al. An unexpected effect of Dermacyn on infected leg ulcers
KR20220131967A (ko) 체표면 병변으로부터 괴사 또는 감염된 조직을 제거하기 위한 조성물
JPWO1996033733A1 (ja) 新規な皮膚欠損症治療剤
HK1065719B (en) Use of thrombin-derived peptides for the therapy of chronic dermal ulcers
EP2068873A2 (fr) Guérison des blessures et des ulcères sous la médiation de l'isoniazide

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, DE

ODRP Renewal fee for the maintenance of a patent

Payment date: 20081231

Year of fee payment: 11

ODBI Application refused